Digital Look

Welcome to Digital Look,
you are not logged in

Tissue Regenix Group (TRX)

10.00p

Select chart: EPS | Dividend | Revenue

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Jan-09	n/a	(2.15)	(0.01)p	n/a	n/a	n/a	n/a	0.0%
31-Jan-10	0.07	(0.74)	(1.35)p	n/a	n/a	n/a	n/a	0.0%
31-Jan-11	0.17	(5.66)	(1.48)p	n/a	n/a	n/a	n/a	0.0%
31-Jan-12	0.11	(2.93)	(0.57)p	n/a	n/a	n/a	n/a	0.0%
31-Jan-13	0.05	(3.97)	(0.55)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Jan-14	1.40	(6.60)	(1.00)p	n/a	n/a	+82%	n/a	0.0%
31-Jan-15	4.20	(5.10)	(0.80)p	n/a	n/a	+n/a	n/a	0.0%

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.